This statistic displays the distribution of drug treatment entrants in Hungary in 2017, by primary drug. In 2017, approximately 63 percent of Hungarian drug treatment entrants were seeking treatment primarily due to cannabis use, while the use of amphetamines was the cause of around 11 percent of treatment entrants.
Distribution of clients entering specialized drug treatment in Hungary in 2017, by primary drug
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Drug users entering treatment in Portugal 2021, by primary drug
- Premium Statistic Drug users entering treatment in Turkey 2017, by primary drug
- Premium Statistic Drug users entering treatment in Croatia 2018, by primary drug
- Premium Statistic Drug treatment entrants in Cyprus 2018, by primary drug
- Premium Statistic Cannabis and cocaine use among Canadian First Nations Adults as of 2015-2016
- Premium Statistic Opinions on the seriousness of the opioid epidemic in the U.S. as of 2017, by age
- Basic Statistic U.S. adults who blame certain sources for the U.S. opioid epidemic as of 2017
- Basic Statistic U.S. adults who blame the pharmaceutical industry for the opioid epidemic as of 2017
- Basic Statistic Opinions on the seriousness of opioid use in U.S. communities as of 2017
- Basic Statistic Opinions on the seriousness of opioid use in U.S. communities in 2017, by ethnicity
About the region
10
- Premium Statistic Number of drug overdose deaths in Hungary 2006-2018
- Premium Statistic MDMA users in Hungary in 2016, by age group
- Premium Statistic Cannabis users in Hungary in 2016, by age group
- Premium Statistic Users entering specialized drug treatment in Hungary 2017, by gender
- Premium Statistic Per capita consumption of alcohol in Hungary 2014-2029
- Premium Statistic Crude birth rate in Hungary 1960-2020
- Basic Statistic Hospital beds in Hungary 2001-2021
- Basic Statistic Antidepressants pharmaceutical consumption in Hungary 2007-2022
- Basic Statistic Cardiovascular system pharmaceutical consumption in Hungary 2007-2022
- Premium Statistic Diabetes drugs consumption in Hungary 2007-2022
Selected statistics
9
- Premium Statistic Deaths by motor vehicle-related injuries in the U.S. 1930-2022
- Premium Statistic Number of worldwide users of cocaine by region 2010-2021
- Premium Statistic Amphetamine users worldwide by region 2010-2020
- Premium Statistic Ecstasy consumers worldwide by region 2010-2021
- Premium Statistic Number of cannabis users worldwide by region 2011-2021
- Premium Statistic U.S. population without health care visits 1997-2018, by gender
- Basic Statistic Adults with severe headache or migraine 1997-2016, by gender
- Basic Statistic Occupational injury death rate in the U.S. 1995-2011 by gender
- Basic Statistic Self-care ability due to quality of health in England 2012, by gender
Other regions
10
- Premium Statistic Drug users in treatment in Albania 2016, by primary drug
- Premium Statistic Drug users in treatment in Kosovo 2016, by primary drug
- Premium Statistic Drug users in treatment in Serbia 2016, by primary drug
- Premium Statistic Drug users in treatment in Bosnia and Herzegovina 2016, by primary drug
- Premium Statistic Cannabis consumption during the COVID-19 pandemic France 2020
- Basic Statistic Distribution of U.S. opioid-related hospitalizations in women 2016, by ethnicity
- Basic Statistic Share of global drug seizures from 2020-2021, by drug type
- Premium Statistic Approval of legalized marijuana among Canadians 2018
- Premium Statistic Share of substance abusers among 15/16-year-olds in Iceland 1998-2017, by substance
- Premium Statistic Distribution of drug treatment entrants in Sweden 2017, by primary drug
Related statistics
10
- Basic Statistic Antihypertensive pharmaceutical consumption in Hungary 2007-2022
- Basic Statistic Hospitals in Hungary 2000-2021
- Premium Statistic Average length of stay in hospital in Hungary 2010-2021
- Premium Statistic Hungarians' satisfaction with the government's actions 2020
- Premium Statistic Price of internal medical examination at private clinics in Hungary 2020
- Premium Statistic Net income of private clinics in Hungary 2018-2019
- Premium Statistic Average number of employees at Hungarian private clinics 2019
- Basic Statistic Distribution of Hungarians who needed medical care during COVID-19 2020
- Premium Statistic Hungarians on increasing healthcare equipment capacity during COVID-19 2020
- Basic Statistic Availability of medical care during COVID-19 Budapest 2020, by gender
Further related statistics
10
- Mental health and substance abuse services industry revenues in the U.S. 2008-2018
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- Total assets of UnitedHealth Group 2007-2023
Further Content: You might find this interesting as well
Statistics
- Mental health and substance abuse services industry revenues in the U.S. 2008-2018
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- Total assets of UnitedHealth Group 2007-2023
EMCDDA. (June 7, 2019). Distribution of clients entering specialized drug treatment in Hungary in 2017, by primary drug [Graph]. In Statista. Retrieved April 19, 2024, from https://www.statista.com/statistics/911855/drug-treatment-entrants-in-hungary-by-primary-drug/
EMCDDA. "Distribution of clients entering specialized drug treatment in Hungary in 2017, by primary drug." Chart. June 7, 2019. Statista. Accessed April 19, 2024. https://www.statista.com/statistics/911855/drug-treatment-entrants-in-hungary-by-primary-drug/
EMCDDA. (2019). Distribution of clients entering specialized drug treatment in Hungary in 2017, by primary drug. Statista. Statista Inc.. Accessed: April 19, 2024. https://www.statista.com/statistics/911855/drug-treatment-entrants-in-hungary-by-primary-drug/
EMCDDA. "Distribution of Clients Entering Specialized Drug Treatment in Hungary in 2017, by Primary Drug." Statista, Statista Inc., 7 Jun 2019, https://www.statista.com/statistics/911855/drug-treatment-entrants-in-hungary-by-primary-drug/
EMCDDA, Distribution of clients entering specialized drug treatment in Hungary in 2017, by primary drug Statista, https://www.statista.com/statistics/911855/drug-treatment-entrants-in-hungary-by-primary-drug/ (last visited April 19, 2024)
Distribution of clients entering specialized drug treatment in Hungary in 2017, by primary drug [Graph], EMCDDA, June 7, 2019. [Online]. Available: https://www.statista.com/statistics/911855/drug-treatment-entrants-in-hungary-by-primary-drug/